Search
Cocrystal Pharma Inc
COCPAdd to Watchlist
1.069USD
+0.019+1.77%
Market hours （ET）Quotes delayed by 15 min
14.73MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30The current earnings forecast score of Cocrystal Pharma Inc is 8.00, ranking 165 out of 387 in the Biotechnology & Medical Research industry. The average price target is 8.00, with a high of 10.00 and a low of 6.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
9.000
Target Price
+773.79%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Cocrystal Pharma Inc
COCP
1
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cocrystal Pharma Inc's price target?
Analysts forecast that Cocrystal Pharma Inc's price target is USD 8.00, with the highest forecast at USD 10.00 and the lowest forecast at USD 6.00.
How have Cocrystal Pharma IncCOCP's recent earnings per share performed?
The market expectation was USD -0.17, while Cocrystal Pharma IncCOCP's earnings per share (EPS) for the previous quarter was USD -0.18. EPS for the next quarter is expected at USD -0.17.
What is the analyst rating for Cocrystal Pharma Inc?
Based on the ratings of Cocrystal Pharma Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.